Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Mateja, Krajc"'
Autor:
Ksenija Strojnik, Vita Setrajcic Dragos, Srdjan Novaković, Vida Stegel, Ana Blatnik, Mateja Krajc
Publikováno v:
Breast Cancer Research and Treatment
Purpose To analyze the prevalence of pathogenic/likely pathogenic variants (P/LPVs) in BRCA1 and BRCA2 genes in the largest cohort of Slovenian male breast cancer (MBC) patients to date and to explore a possible correlation between the Slovenian foun
Autor:
Barbara Gazic, Tea Nizic-Kos, Vida Stegel, Nikola Besic, Srdjan Novaković, Ana Blatnik, Petra Škerl, Mateja Krajc
Publikováno v:
Annals of Surgical Oncology. 28:2561-2570
Currently, data on pathogenic variants in the CHEK2 gene and their impact on cancer risk are lacking. This study aimed to explore the characteristics of breast cancer (BC) patients from families with CHEK2 pathogenic variants in Slovenia. In the year
Autor:
Vida Stegel, Barbara Gazic, Mateja Krajc, Ana Blatnik, Andraz Perhavec, Srdjan Novaković, Sebastijan Merlo, Andreja Gornjec
Publikováno v:
Radiology and Oncology, Vol 54, Iss 2, Pp 180-186 (2020)
Radiology and Oncology
Radiology and Oncology
Background We assessed the prevalence, localization, type and outcome of occult cancer at risk-reducing salpingo-oophorectomy or salpingectomy (RRSO) in asymptomatic carriers of pathogenic or likely pathogenic BRCA1/2 variants and high-risk BRCA1/2 n
Autor:
E Skof, Mateja Krajc, Ana Blatnik, S Bebar, V Setrajcic Dragos, Srdjan Novaković, V Kloboves-Prevodnik, Vida Stegel, S Miceska
Publikováno v:
Ovarian cancer.
Introduction/Background* Since approval of PARP inhibitor olaparib, testing for germline BRCA 1/2 (gBRCA) gene mutations from blood and testing from formalin-fixed-paraffin-embedded (FFPE) tumor tissue for detection of somatic BRCA 1/2 (sBRCA) gene m
Autor:
VA Mesaric, Mateja Krajc, E Skof, Vida Stegel, M Banjac, K Strojnik, Srdjan Novaković, A Blatnik, K Drusany Staric, S Hotujec
Publikováno v:
Ovarian cancer.
Introduction/Background* In Slovenia, ovarian cancer is diagnosed in approximately 160 women per year. The majority of patients are diagnosed with advanced disease and the survival rate is poor. 20 – 30% of cases can be attributed to germline patho
Publikováno v:
European journal of surgical oncology, vol. 47, no. 8, pp. 1900-1906, 2021.
European journal of surgical oncology, str. 1900-1906, Vol. 47, no. 8, Aug. 2021
COBISS-ID: 6045447
European journal of surgical oncology, str. 1900-1906, Vol. 47, no. 8, Aug. 2021
COBISS-ID: 6045447
Objectives. Risk-reducing mastectomy (RRM) is one of key prevention strategies in female carriers of germline BRCA pathogenic/likely pathogenic variants (PV/LPV). We retrospectively investigated the rate, timing and longitudinal trends of bilateral R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a845e751a5beae9844a5fe6078e91c44
https://dirros.openscience.si/Dokument.php?id=20594&dn=
https://dirros.openscience.si/Dokument.php?id=20594&dn=
Autor:
Vesna Zadnik, Kristijana Hertl, Peter B. Dean, Katja Jarm, Maja Primic Žakelj, Cveto Šval, Lawrence von Karsa, Maksimiljan Kadivec, Urban Zdešar, Barbara Gazic, Igor Josipović, Mateja Krajc, Veronika Kutnar, Mateja Kurir Borovčić, Janez Žgajnar
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0258343 (2021)
PLoS ONE
PLoS ONE
Setting The organised, population-based breast cancer screening programme in Slovenia began providing biennial mammography screening for women aged 50–69 in 2008. The programme has taken a comprehensive approach to quality assurance as recommended
Autor:
David Humberto Marmolejo, Mark Yu Zheng Wong, Svetlana Bajalica-Lagercrantz, Marc Tischkowitz, Judith Balmaña, Attila Balázs Patócs, Pierre Chappuis, Chrystelle Colas, Maurizio Genuardi, Maria Haanpää, Hildegunn Hoberg Vetti, Nicoline Hoogerbrugge, Arvids Irmejs, Tiina Kahre, Barbara Klink, Mateja Krajc, Tamara Hussong Milagre, Robin de Putter, Verena Steinke-Lange, Karin Wadt, Katharina Wimmer
Publikováno v:
European Journal of Medical Genetics, 64, 12
European Journal of Medical Genetics, 64
European Journal of Medical Genetics, 64
Item does not contain fulltext Hereditary breast and ovarian cancer (HBOC) is a syndrome defined by an increased risk of developing breast and/or ovarian cancer most commonly due to germline disease-causing variants in the BRCA1 and BRCA2 genes, but
Publikováno v:
Radiology and Oncology
Radiology and Oncology, Vol 54, Iss 3, Pp 335-340 (2020)
Radiology and oncology, str. 335-340, X, Vol. 54, no. 3, 2020 : Tabele
COBISS-ID: 32649472
Radiology and Oncology, Vol 54, Iss 3, Pp 335-340 (2020)
Radiology and oncology, str. 335-340, X, Vol. 54, no. 3, 2020 : Tabele
COBISS-ID: 32649472
Background The aim of the study was to assess the proportion of women that would be classified as at above-average risk of breast cancer based on the 10 year-risk prediction of the Slovenian breast cancer incidence rate (S-IBIS) program in two presum
Autor:
Sonja Tomšič, Mateja Krajc, Katarina Lokar, Tina Žagar, Vesna Zadnik, D. Gareth Evans, Janez Žgajnar, Ana Blatnik
Publikováno v:
Slovenian Journal of Public Health
Slovenian Journal of Public Health, Vol 59, Iss 4, Pp 211-218 (2020)
Slovenian Journal of Public Health, Vol 59, Iss 4, Pp 211-218 (2020)
One of the most consistent models for estimating personalized breast cancer (BC) risk is the Tyrer-Cuzick algorithm that is incorporated into the International Breast Cancer Intervention Study (IBIS) software. Our main objective was to provide criter